866-997-4948(US-Canada Toll Free)

2012-2022 Report on Global Alzheimers Disease Market Competition, Status and Forecast, Market Size by Players, Regions, Type, Application

Published By :

QYResearch

Published Date : Mar 2017

Category :

Pharmaceutical

No. of Pages : 104 Pages

This report studies the Alzheimers Disease Drug market status and outlook of global and major regions, from angles of players, regions, product types and end industries; this report analyzes the top players in global and major regions, and splits the Alzheimers Disease Drug market by product type and applicationsend industries.

In the last several years, global market of alzheimers disease drug change huge. In 2016, global revenue of alzheimers disease drug is nearly 3161.3 M USD. And the global growth rate is at -10.95% from 2012 to 2016


The major players in global Alzheimers Disease Drug market include
Allergan
Eisai
Novartis
Daiichi Sankyo
Merz Pharma
Pfizer
Johnson & Johnson
Lundbeck.

Geographically, this report is segmented into several key Regions, with Sales, Sales, revenue, Market Share (%) and Growth Rate (%) of Alzheimers Disease Drug in these regions, from 2012 to 2022 (forecast), covering
North America
Europe
China
Japan
Row


On the basis of product, the Alzheimers Disease Drug market is primarily split into
Donepezil
Memantine
Rivastigmine

On the basis on the end usersapplications, this report covers
Early to Moderate Stages
Moderate to Severe Stages

 

Table of Contents

1SUMMARY
1.1 Disease Definition
1.2 Key AD Statistics
1.3Current Treatment
1.4Research Investment
1.5 Key Research Areas
2Disease Burden
2.1 Overview
2.2 Disease Burden
2.2.1 Population Burden of Alzheimers disease
.2.2.2 Economic Burden of Alzheimers disease
2.3 Risk Factors of Alzheimers disease
2.4 Biology
2.4.1 Cause of Alzheimers disease
Table Cause of Alzheimers disease
2.4.2 Progression of Alzheimers disease
2.5 Treatments for Alzheimers disease
3 Global Alzheimers Disease Drug Market Competition by ManufacturersBrand
3.1 Global Alzheimers Disease Drug Sales (M Units) and Share by Manufacturers (2012-2017)
3.2 Global Alzheimers Disease Drug Revenue (M USD) and Share by Manufacturers (2012-2017)
3.3 Global Alzheimers Disease Drug Average Price (USDUnit) by Manufacturers (2012-2017)
3.4 Manufacturers Alzheimers Disease Drug Headquarters, Found Date, Product Types
3.5 Alzheimers Disease Drug Market Competitive Situation and Trends
3.5.1 Alzheimers Disease Drug Market Concentration Rate
3.5.2 Alzheimers Disease Drug Market Share (%) of Top 3 and Top 5 Manufacturers
3.5.3 Mergers & Acquisitions, Expansion
4 Global Alzheimers Disease Drug Sales (M Units), Revenue (M USD) by Regions (2012-2017)
4.2 Global Alzheimers Disease Drug Sales (M Units) and Market Share (%) by Regions (2012-2017)
4.3 Global Alzheimers Disease Drug Revenue (M USD) and Market Share (%) by Regions (2012-2017)
4.3 Global Alzheimers Disease Drug Sales (M Units), Revenue (M USD), Price (USDUnit) and Gross Margin (%) (2012-2017)
4.5 North America Alzheimers Disease Drug Sales (M Units), Revenue (M USD), Price (USDUnit) and Gross Margin (%) (2012-2017)
4.6 Europe Alzheimers Disease Drug Sales (M Units), Revenue (M USD), Price (USDUnit) and Gross Margin (%) (2012-2017)
4.7 China Alzheimers Disease Drug Sales (M Units), Revenue (M USD), Price (USDUnit) and Gross Margin (%) (2012-2017)
4.8 Japan Alzheimers Disease Drug Sales (M Units), Revenue (M USD), Price (USDUnit) and Gross Margin (2012-2017)
5 Global Alzheimers Disease Drug Sales, Revenue, Price Trend by Types
5.1 Global Alzheimers Disease Drug Sales (M Units) and Market Share (%) by Types (2012-2017)
5.2 Global Alzheimers Disease Drug Revenue and Market Share (%) by Types (2012-2017)
5.3 Global Alzheimers Disease Drug Price (USDUnit) by Type (2012-2017)
5.4 Global Alzheimers Disease Drug Sales Growth by Type (2012-2017)
6 Global Alzheimers Disease Drug Market Analysis by Applications
6.1 Global Alzheimers Disease Drug Sales (M Units) and Market Share (%) by Applications (2012-2017)
6.2 Global Alzheimers Disease Drug Sales Growth Rate (%) by Applications (2012-2017)
7 Analysis of Alzheimers Disease Drug Industry Key Manufacturers
7.1 Allergan
7.1.1 Company Profile
7.1.2 Product Information
7.1.3 Sales, Price, Cost, Gross, and Revenue
7.2 Eisai
7.2.1 Company Profile
7.2.2 Product Information
7.2.3 Sales, Price, Cost, Gross, and Revenue
7.3 Novartis
7.3.1 Company Profile
7.3.2 Product Information
7.3.3 Sales, Price, Cost, Gross, and Revenue
7.4 Daiichi Sankyo
7.4.1 Company Profile
7.4.2 Product Information
7.4.3 Sales, Price, Cost, Gross, and Revenue
7.5 Merz Pharma
7.5.1 Company Profile
7.5.2 Product Information
7.5.3 Sales, Price, Cost, Gross, and Revenue
7.6 Pfizer
7.6.1 Company Profile
7.6.2 Product Information
7.6.3 Sales, Price, Cost, Gross, and Revenue
7.7 Johnson & Johnson
7.7.1 Company Profile
7.7.2 Product Information
7.7.3 Sales, Price, Cost, Gross, and Revenue
7.8 Lundbeck
7.8.1 Company Profile
7.8.2 Product Information
7.8.3 Sales, Price, Cost, Gross, and Revenue
8 Global Alzheimers Disease Drug Market Forecast (2017-2022)
8.1 Global Alzheimers Disease Drug Sales (M Units), Revenue (M USD) Forecast (2017-2022)
8.1.1 Global Alzheimers Disease Drug Sales (M Units) and Growth Rate (%) Forecast (2017-2022)
8.1.2 Global Alzheimers Disease Drug Revenue (M USD) and Growth Rate (%) Forecast (2017-2022)
8.1.3 Global Alzheimers Disease Drug Price and Trend Forecast (2017-2022)
8.2 Global Alzheimers Disease Drug Sales (M Units) and Revenue (M USD) Forecast by Regions (2017-2022)
8.2.1 North America Alzheimers Disease Drug Sales (M Units) and Revenue (M USD) Forecast (2017-2022)
8.2.2 Europe Alzheimers Disease Drug Sales (M Units) and Revenue (M USD) Forecast (2017-2022)
8.2.3 China Alzheimers Disease Drug Sales (M Units) and Revenue (M USD) Forecast (2017-2022)
8.2.4 Japan Alzheimers Disease Drug Sales (M Units) and Revenue (M USD) Forecast (2017-2022)
8.3 Global Alzheimers Disease Drug Sales (M Units), Revenue (M USD), Price (USDUnit) Forecast by Type (2017-2022)
8.4 Global Alzheimers Disease Drug Sales (M Units) Forecast by Application (2017-2022)
9 Alzheimers drug-development pipeline
9.1 Phase III
9.2 Phase II
9.3 Phase I
9.4 Biomarkers
10 Marketing Strategy Analysis, DistributorsTraders
10.1 Marketing Channel
10.2 Market Positioning
10.2.1 Market Positioning
10.2.2 Brand Strategy
10.3 DistributorsTraders List
11 Research Findings and Conclusion
12 Methodology and Data Source
12.1 MethodologyResearch Approach
12.1.1 Research ProgramsDesign
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Disclaimer
12.4 Author List


 

List of Table

List of Tables and Figures

Table Global Alzheimers disease Statistics
Table Global Alzheimers disease Current Treatmen
Table Global Alzheimers disease Research Investment
Table Global Alzheimers disease Key Research Areas
Figure Prevalence of AD in 65+ population in the U.S.
Figure Prevalence of AD in 65+ population in the EU
Figure Prevalence of AD in 65+ population in the China
Figure Prevalence of AD in 65+ population in the Japan
Figure Prevalence of AD in 65+ population in the MEA.
Table Estimates of Annual Expenses for AD and Other Dementia
Table Risk Factors of Alzheimers disease
Table Progression of Alzheimers disease
Table Drug for Alzheimers disease
Table Major Manufacturers for Alzheimers disease Drugs and Their Brand
Table Global Alzheimers Disease Drug Sales (M Units) of Key Manufacturers (2012-2017)
Figure 2016 Alzheimers Disease Drug Sales Share (%) by Manufacturers
Figure 2017 Alzheimers Disease Drug Sales Share (%) by Manufacturers
Table Global Alzheimers Disease Drug Revenue (M USD) by Manufacturers (2012-2017)
Table 2016 Global Alzheimers Disease Drug Revenue Share (%) by Manufacturers
Table 2017 Global Alzheimers Disease Drug Revenue Share (%) by Manufacturers
Table Global Market Alzheimers Disease Drug Average Price (USDUnit) of Key Manufacturers (2012-2017)
Figure Global Market Alzheimers Disease Drug Average Price (USDUnit) of Key Manufacturers in 2016
Table Manufacturers Alzheimers Disease Drug Headquarters and Found Date
Table Manufacturers Alzheimers Disease Drug Brand
Table 2016 Global Alzheimers Disease Drug Revenue Share (%) by Manufacturers
Figure Alzheimers Disease Drug Market Share (%) of Top 3 Manufacturers
Figure Alzheimers Disease Drug Market Share (%) of Top 5 Manufacturers
Table Mergers & Acquisitions, Expansion
Table Global Alzheimers Disease Drug Sales (M Units) by Regions (2012-2017)
Table Global Alzheimers Disease Drug Sales Market Share by Regions (2012-2017)
Figure 2016 Global Alzheimers Disease Drug Sales Market Share (%) by Regions
Figure 2017 Global Alzheimers Disease Drug Sales Market Share (%) by Regions
Table Global Alzheimers Disease Drug Revenue (M USD) by Regions (2012-2017)
Table Global Alzheimers Disease Drug Revenue Market Share (%) by Regions (2012-2017)
Figure 2016 Global Alzheimers Disease Drug Revenue Market Share (%) by Regions
Figure 2017 Global Alzheimers Disease Drug Revenue Market Share (%) by Regions
Table Global Alzheimers Disease Drug Sales (M Units), Revenue (M USD), Price (USDUnit) and Gross Margin (%) (2012-2017)
Table North America Alzheimers Disease Drug Sales (M Units), Revenue (M USD), Price (USDUnit) and Gross Margin (%) (2012-2017)
Table Europe Alzheimers Disease Drug Sales (M Units), Revenue (M USD), Price (USDUnit) and Gross Margin (%) (2012-2017)
Table China Alzheimers Disease Drug Sales (M Units), Revenue (M USD), Price (USDUnit) and Gross Margin (%) (2012-2017)
Table Japan Alzheimers Disease Drug Sales (M Units), Revenue (M USD), Price (USDUnit) and Gross Margin (%) (2012-2017)
Table Global Alzheimers Disease Drug Sales (M Units) by Types (2012-2017)
Table Global Alzheimers Disease Drug Sales Share (%) by Types (2012-2017)
Figure 2016 Sales Market Share (%) of Alzheimers Disease Drug by Types
Figure 2017 Sales Market Share (%) of Alzheimers Disease Drug by Types
Table Global Alzheimers Disease Drug Revenue (M USD) by Types (2012-2017)
Table Global Alzheimers Disease Drug Revenue Share (%) by Types (2012-2017)
Figure 2016 Revenue Market Share (%) of Alzheimers Disease Drug by Types
Figure 2017 Revenue Market Share (%) of Alzheimers Disease Drug by Types
Table Global Alzheimers Disease Drug Price (USDUnit) by Types (2012-2017)
Figure Global Alzheimers Disease Drug Sales Growth (%) by Type (2012-2017)
Table Global Alzheimers Disease Drug Sales (M Units) by Applications (2012-2017)
Table Global Alzheimers Disease Drug Sales Market Share (%) by Applications (2012-2017)
Figure Global Alzheimers Disease Drug Sales Market Share (%) by Applications in 2016
Figure Global Alzheimers Disease Drug Sales Market Share (%) by Applications in 2017
Figure Global Alzheimers Disease Drug Sales Growth Rate (%) by Applications (2012-2017)
Table Allergan Company Profile
Table Alzheimers Disease Drug Product Introduction of Allergan
Table Alzheimers Disease Drug Ssles (M Unit), Price (USDUnit), Cost (USDUnit), Gross (USDUnit), Revenue (M USD) and Gross Margin of Allergan 2012-2017
Table Eisai Company Profile
Table Alzheimers Disease Drug Product Introduction of Eisai
Table Alzheimers Disease Drug Production (M Unit), Price (USDUnit), Cost (USDUnit), Gross (USDUnit), Revenue (M USD) and Gross Margin of Eisai 2012-2017
Table Novartis Company Profile
Table Alzheimers Disease Drug Product Introduction of Novartis
Table Alzheimers Disease Drug Production (M Unit), Price (USDUnit), Cost (USDUnit), Gross (USDUnit), Revenue (M USD) and Gross Margin of Novartis 2012-2017
Table Daiichi Sankyo Company Profile
Table Alzheimers Disease Drug Product Introduction of Daiichi Sankyo
Table Alzheimers Disease Drug Production (M Unit), Price (USDUnit), Cost (USDUnit), Gross (USDUnit), Revenue (M USD) and Gross Margin of Daiichi Sankyo 2012-2017
Table Merz Pharma Company Profile
Table Alzheimers Disease Drug Product Introduction of Merz Pharma
Table Alzheimers Disease Drug Production (M Unit), Price (USDUnit), Cost (USDUnit), Gross (USDUnit), Revenue (M USD) and Gross Margin of Merz Pharma 2012-2017
Table Pfizer Company Profile
Table Alzheimers Disease Drug Product Introduction of Pfizer
Table Alzheimers Disease Drug Production (M Unit), Price (USDUnit), Cost (USDUnit), Gross (USDUnit), Revenue (M USD) and Gross Margin of Pfizer 2012-2017
Table Johnson & Johnson Company Profile
Table Alzheimers Disease Drug Product Introduction of Johnson & Johnson
Table Alzheimers Disease Drug Production (M Unit), Price (USDUnit), Cost (USDUnit), Gross (USDUnit), Revenue (M USD) and Gross Margin of Johnson & Johnson 2012-2017
Table Lundbeck Company Profile
Table Alzheimers Disease Drug Product Introduction of Lundbeck
Table Alzheimers Disease Drug Production (M Unit), Price (USDUnit), Cost (USDUnit), Gross (USDUnit), Revenue (M USD) and Gross Margin of Lundbeck 2012-2017
Figure Global Alzheimers Disease Drug Sales (M Units) and Growth Rate (%) Forecast (2017-2022)
Figure Global Alzheimers Disease Drug Revenue (M USD) and Growth Rate (%) Forecast (2017-2022)
Figure Global Alzheimers Disease Drug Price and Trend Forecast (2017-2022)
Table Global Alzheimers Disease Drug Sales (M Units) Forecast by Regions (2017-2022)
Figure North America Alzheimers Disease Drug Sales (M Units) and Growth Rate (%) Forecast (2017-2022)
Figure North America Alzheimers Disease Drug Revenue and Growth Rate (%) Forecast (2017-2022)
Figure Europe Alzheimers Disease Drug Sales (M Units) and Growth Rate (%) Forecast (2017-2022)
Figure Europe Alzheimers Disease Drug Revenue and Growth Rate (%) Forecast (2017-2022)
Figure China Alzheimers Disease Drug Sales (M Units) and Growth Rate (%) Forecast (2017-2022)
Figure China Alzheimers Disease Drug Revenue and Growth Rate (%) Forecast (2017-2022)
Figure Japan Alzheimers Disease Drug Sales (M Units) and Growth Rate (%) Forecast (2017-2022)
Figure Japan Alzheimers Disease Drug Revenue and Growth Rate (%) Forecast (2017-2022)
Table Global Alzheimers Disease Drug Sales (M Unit) Forecast by Type (2017-2022)
Table Global Alzheimers Disease Drug Revenue (M USD) Forecast by Type (2017-2022)
Table Global Alzheimers Disease Drug Price (USDUnit) Forecast by Type (2017-2022)
Table Global Alzheimers Disease Drug Sales (M Units) Forecast by Application (2017-2022)
Figure Agents currently in clinical trials for AD
Table Agents currently in phase III of development and their mechanism of action
Table Agents currently in phase II of AD drug development and their mechanism of action
Table Agents currently in phase I of development and their mechanism of action
Table Percent of trials with specific biomarkers included
Figure Marketing Channel for Alzheimers Disease
Figure Alzheimers Disease Marketing Channel
Table DistributorsTraders List
Table Research ProgramsDesign for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources

Make an enquiry before buying this Report

Please fill the enquiry form below.

  • Full Name *
  • Your Email *
  • Job Title *
  • Company *
  • Phone No. * (Pls. Affix Country Code)
  • Message
  • Security Code *